Chengdu Suncadia Medicine Co., Ltd.
Clinical trials sponsored by Chengdu Suncadia Medicine Co., Ltd., explained in plain language.
-
New pill offers hope for PNH patients with persistent anemia
Disease control CompletedThis study tested an experimental pill called HRS-5965 in 39 adults with paroxysmal nocturnal hemoglobinuria (PNH) who still had anemia despite using standard anti-C5 antibody drugs. The goal was to see if the pill could raise hemoglobin levels and reduce the need for blood trans…
Phase: PHASE3 • Sponsor: Chengdu Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 12:03 UTC
-
Healthy volunteers test two forms of experimental drug
Knowledge-focused CompletedThis study tested how well two different forms of the drug HRS-5965 (capsules vs. tablets) are absorbed by the body. It involved 16 healthy men aged 18 to 45. The goal was to see if the two forms work the same way, which helps decide the best form for future use.
Phase: PHASE1 • Sponsor: Chengdu Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 12:10 UTC
-
Liver function may affect how drug works in kidney disease
Knowledge-focused CompletedThis study looked at how the drug HRS-5965 is processed by the body in people with mild or moderate liver impairment compared to those with normal liver function. It involved 24 adults with certain kidney diseases. The goal was to understand safety and drug levels, not to treat t…
Phase: PHASE1 • Sponsor: Chengdu Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Apr 26, 2026 19:35 UTC